ARDS Clinical Trials 2022

Browse 23 Ards Medical Studies Across 47 Cities

3 Phase 3 Trial · 79 Ards Clinics

Reviewed by Michael Gill, B. Sc.
Photo of Edmonton 1
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Vocal Cord Markingfor Respiratory Distress Syndrome

Edmonton, Canada
< 18
All Sexes
Tracheal intubation remains a common procedure in the neonatal intensive care unit (NICU) and the delivery room (DR). Current guidelines recommend Estimation of correct endotracheal tube (ETT) insertion Our hospital policy recommends to estimate the correct depth (cm) of tube placement by measuring the nasal-ear-tragus length using the "7-8-9 rule" when the endotracheal tube is placed orally. Using this formula an infant weighing 1kg would be intubated to a depth of 7cm, a 2kg infant to a depth of 8cm, and a 3kg infant to a depth of 9cm from the upper lip. With the new 2015 guidelines, ETT depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm or by using the "initial endotracheal tube insertion depth" table. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear. However, studies using NTL reported that using this technique only resulted in correct ETT placement in 56% of cases. Every ETT has markings on the tube, which are called vocal cord markings, which are to be used to provide a guidance to how deep to place the ETT into the trachea. There has been npc study to compare the vocal cord markings with the current approach of NTL. The current study aims to determine if the use of vocal cord markings during intubation increases percentage of correct endotracheal tube placement compared to NTL in preterm and term infants.
Recruiting
Has No Placebo
23 Ards Clinical Trials Near Me
Liberty, MO
Mesquite, TX
Edmonton, Canada
Chapel Hill, NC
More Trial Locations
An interactive map to display trial locations for Kit Bartalos, PRX Research, Royal Alexandra Hospital, University of North Carolina, and 68 more locations.
Most Popular References for Ards Clinical Trials
Frequency
Citation
Top Treatments for Ards Clinical Trials
Treatment Name
Active Ards Clinical Trials
All Time Trials for Ards
First Recorded Ards Trial
Trials
Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells
1
1
2021
Top Cities for Ards Clinical Trials
City
Active Ards Clinical Trials
Top Active Site for Ards Clinical Trials
Trial List
Recently Completed Studies with FDA Approved Treatments for Ards
Treatment
Year
Mechanism of Action
Sponsor
Active Ards Clinical Trials
Lucinactant
2020
Lucinactant + Sinapultide
Windtree Therapeutics
0
agenT-797
2020
MiNK Therapeutics
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 7th, 2021

Last Reviewed: August 4th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.